Key result
Higher AI-derived ECG delta-age predicts ~83% greater all-cause mortality.
Why the study?
The difference between AI-derived ECG-age and chronological age (delta-age) has been proposed to predict adverse outcomes, but its prognostic value has not been systematically established.
Does a higher AI-derived ECG delta-age predict increased mortality in adults?
Does a higher AI-derived ECG delta-age predict increased mortality in adults?
Answers are grounded in this paper and cite their sources.
A higher AI-derived ECG delta-age is associated with an 83% increased risk of all-cause mortality, highlighting its potential as a non-invasive biomarker for cardiovascular ageing.
Background Electrocardiogram (ECG)-age, an age estimate derived from ECGs using artificial intelligence (AI), has emerged as a potential biomarker of cardiovascular ageing. The difference between ECG-age and chronological age, known as delta-age, has been proposed as a predictor of adverse outcomes, but its prognostic value has not yet been systematically established. Purpose To assess the prognostic value of AI-derived ECG-age and delta-age in predicting mortality. Methods We conducted a systematic review and meta-analysis of retrospective cohort studies reporting associations between ECG-age or delta-age and clinical outcomes. Databases searched included LILACS, Scielo, MEDLINE, ScienceDirect, EMBASE, CENTRAL, CINAHL, Web of Science and Scopus, from inception to 1 May 2025. Eligible studies included participants aged ≥16 years and reported outcomes such as all-cause mortality, cardiovascular mortality, stroke, or atrial fibrillation. Two reviewers independently screened articles and extracted data. A random-effects meta-analysis (Hartung-Knapp method) was performed. The meta-analysis was registered in PROSPERO (CRD420251042467). Results Ten retrospective cohort studies were included in the qualitative synthesis, with prognostic analysis populations ranging from 2,183 to 234,036 individuals. AI-derived ECG-age was calculated from 12-lead ECGs using deep learning models. Most studies utilized ECG waveforms, and only one analyzed ECG images. Across studies, a higher delta-age (≥6–10 years) was consistently associated with an increased risk of adverse outcomes, while four studies reported a statistically significant protective association in lower delta-age groups. Most studies adjusted for age, sex, and comorbidities. Seven studies assessed the association between delta-age and mortality; three of these included external validation cohorts, resulting in 11 datasets analysed. The pooled hazard ratio (HR) for all-cause mortality in individuals with higher delta-age was 1.83 (95% CI: 1.45–2.32), with substantial heterogeneity (I² = 82.9%). Conclusion AI-derived ECG-age, particularly when significantly higher than chronological age, is associated with an increased risk of mortality. These findings support its potential role as a novel, non-invasive biomarker of cardiovascular ageing. Prospective studies are needed to confirm its clinical utility and to establish its role in individual risk stratification.
No takes yet. Share an insight, caveat, or question.
Bozzi et al. (2026) studied this question. A higher delta-age (≥6 years) predicted increased all-cause mortality with a pooled HR of 1.83 in individuals derived from AI-based ECG-age assessments.
Synapse has enriched 10 related papers. Consider them for comparative context: